Stakeholders have the right to know whether the industry and patient representatives on the HTA Review reference committee objected to the declaration of interest, primarily because it invalidates the input of the people and organisations they claim to represent.
It's in the name - a stakeholder with an interest has a 'stake', not a conflict
February 22, 2024 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
Who remembers the 'Vancouver' poster? We have a rerun
September 22, 2026 - - Latest News -
If there is a productivity gain in the process, then it should be passed on
September 22, 2026 - - Latest News -
Given the official use of AI, a cease and desist would not be unreasonable
September 22, 2026 - - Latest News -
Treasury has moved on from the PBS, but the policies built on its error have not
September 21, 2026 - - Latest News -
Nyrada banks $12 million as directors contribute in nearly half
September 21, 2026 - - Australian Biotech -
Telix announces takeover of ITM to create a global radiopharmaceutical powerhouse
September 21, 2026 - - Australian Biotech -
Only 2 per cent of Australians can name the signs of a heart condition behind one in four strokes
September 21, 2026 - - Latest News
